Guidance+1
Current guidance was classified as raised.
Low confidenceEarnings thesis change · rubric v1.0
CE Celanese Corp
Fiscal Q3 FY2026 · quarter ended September 30, 2026 · reported 2026-11-02
SEC filings and exhibits only
Earnings filing (8-K) · Latest 10-Q filings
Last updated: Nov 2, 2026 at 9:28 PM UTC
Earnings filing (8-K) · Latest 10-Q filings
Last updated: Nov 2, 2026 at 9:28 PM UTC
ACCOUNTING RISK · CLEAR
No auditor changes, restatements, late filings, or listing notices in the last 12 months.
from SEC filings · 2026-10-09
Thesis change
Strengthened
Legacy analysis
Legacy analysis: only the dimensions classifiable by the pre-v1 pipeline are shown.
- Legacy analysis: scored by the pre-v1 pipeline; deep evidence has not been re-verified.
- 5 thesis dimension(s) lack comparable evidence
Reported facts
GAAP facts are reported by the company. Comparable figures are EarnIQ arithmetic using only quantified adjustments disclosed in the linked SEC exhibit.
Reported EPS and revenue have not yet been extracted from the filing.
Earnings quality
From 10-Q / 10-K XBRL filings. Sloan (1996) accruals: high accruals relative to assets have historically preceded earnings disappointments. Descriptive research, not a prediction.
Weak — accruals are doing the heavy lifting
Reported profits have been driven more by accounting accruals than cash. Latest quarter: accruals equal 1.9% of assets — in the weakest quintile of large caps.
CY2018Q4Accruals / assets (TTM)CY2022Q4
Depreciation is disclosed annually by most filers, so quarterly values blend actuals with estimates — flagged on every reading. Method: TTM Sloan accruals ÷ average assets, scored 1–5 by quintile.
1. Three decisive changes
Largest quantified changes versus the company's own history.
+620.8%
Net income — year over year
$125.0M vs $-24.0M a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
+67.3%
Operating income — year over year
$276.0M vs $165.0M a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
+30.4%
Gross profit — year over year
$618.0M vs $474.0M a year ago · quarter ended Jun 30, 2026 · from 10-Q XBRL filings.
2. Was it already expected?
Consensus classifications require timestamped pre-report snapshots and eight-quarter surprise history.
| Item | Actual | Expected | Gap | Class |
|---|---|---|---|---|
| Consensus comparison coming soon. | ||||
3. Management consistency
Only attributable, measurable and dated commitments are counted. Delivery record: 3 being tracked.
| Promise | Target | Outcome | Status | Evidence |
|---|---|---|---|---|
| expect the transaction to sell an additional 19 percent of the Nutrinova food ingredients joint venture to close in the fourth quarter of 2026acquisition · made 2026-11-02 | 19 percentfourth quarter of 2026 | — | Pending | 8-K 0001306830-26-0001 |
| expect to reach approximately $650 million in divestiture sales proceeds by year end 2027other · made 2026-11-02 | approximately $650 millionend of 2027 | — | Pending | 8-K 0001306830-26-0001 |
| expect to have generated over $1.5 billion in free cash flow over the past two years by the end of 2026other · made 2026-11-02 | over $1.5 billionend of 2026 | — | Pending | 8-K 0001306830-26-0001 |
4. What matters next
One deciding measurable condition plus up to two supporting checkpoints.
The deciding condition
EPS for the guided period lands within $6–$6.25
StrengthensReported EPS above $6.25
InvalidatesReported EPS below $6
Management expects full-year 2026 adjusted earnings per share of approximately $6.00 to $6.25 and increased the free cash flow outlook to a range of $750 to $800 million.
5. Risks that changed
New or materially worsened items only; unchanged boilerplate is omitted.
No new or materially worsened risk has been source-verified.
From 10-K filings · EDGAR
35
new risk disclosures added
25
old ones removed
FY2025 10-K vs prior year, boilerplate filtered out — these are idiosyncratic changes, and tone is about unchanged.
New risk disclosure #1
“indebtedness, pay dividends, or repurchase our Common Stock. The Credit Agreements, the Indentures and the Receivables Purchase Agreement governing our receivables securitization facility each contain various covenants t…”
New risk disclosure #2
“Contents may subject us to significant competitive, reputational, cybersecurity, legal, regulatory, operational and other risks. If our products and services incorporating AI fail to operate as anticipated or as well as …”
New risk disclosure #3
“• A supplier's inability to meet our delivery orders, a supplier's decision not to fulfill orders or to terminate a supply contract or our inability to obtain or renew supply contracts on favorable terms; 16 Table of…”
6. Evidence drawer
Source location, short anchor and visible arithmetic for every verified claim.
DC1 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Net income · quarter ended 2026-06-30Net income: +620.8% year over year
(125,000,000 − -24,000,000) ÷ 24,000,000 = +620.8% YoYDC2 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Operating income · quarter ended 2026-06-30Operating income: +67.3% year over year
(276,000,000 − 165,000,000) ÷ 165,000,000 = +67.3% YoYDC3 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Gross profit · quarter ended 2026-06-30Gross profit: +30.4% year over year
(618,000,000 − 474,000,000) ÷ 474,000,000 = +30.4% YoYWN1 8-K Exhibit 99.1 (earnings release, via EDGAR)
Guidance disclosed for Q3 FY2026EPS for the guided period lands within $6–$6.25
Strengthens: Reported EPS above $6.25 · Invalidates: Reported EPS below $6